Vorinostat Terminated Phase 2 / 3 Trials for Stage IIIB or IV Non-Small Cell Lung Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2 / 3
clinicaltrials.gov IdentifierTitleDrugs